Hear Me Read 2021 Clinical Trial
Hearing Loss, Deafness, Hearing Disorders in Children
About this trial
This is an interventional treatment trial for Hearing Loss focused on measuring App, Speech and Language, Tablet, Digital, Literacy, Hearing Loss, Speech Therapy
Eligibility Criteria
Inclusion Criteria:
- Male and female children ages 3.0-5.11 (5 years and 11 months) at time of initial assessment and:
- Bilateral Sensorineural or mixed hearing loss at least (PTA≥30dB)
- Auditory neuropathy in both ears
Exclusion Criteria:
- English not primary language
- Standard score CLS >2 SD from normal on CELF-P3
Sites / Locations
- Nationwide Children's Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Speech Language Therapy
Speech Language Therapy + Digital Phase
Children who are deaf/hard of hearing will receive standard of care speech and language therapy with a speech language pathologist. Reading time is prescribed 20 min, 3x/week.
Children who are deaf/hard of hearing will receive standard of care speech and language therapy with a speech language pathologist with the addition of the digital app named, Hear Me Read, that will be used to achieve reading, speech and language goals through interactive digital storybook reading. Reading time is prescribed 20 min, 3x/week.